St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
NCT: NCT05092022 · RECRUITING
Brief Summary
This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.
Frequently Asked Questions
What is St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic?
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic is a clinical trial registered under NCT05092022. Current status: RECRUITING.
What is the status of NCT05092022?
The current status of NCT05092022 (St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic) is: RECRUITING.
When did St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic start?
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic started on 2023-09-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.